| Product Name |
MF |
CAS |
Details |
| 2-Amino-5-nitro pyridine |
C5H5N3O2 |
4214-76-0 |
|
| N-[3-[[4-[[Cyclohexyl[(cyclohexylamino)carbonyl]amino]carbonyl ]-2-methoxyphenyl] methyl]-1-methyl-1H-indol-5-yl]carbamic acid cyclopentyl ester |
C37H48N4O5 |
1391990-94-5 |
|
| 5-(2-Bromoethyl)-2,3-dihydro-1-benzofuran |
C10H11BrO |
127264-14-6 |
|
| 1-methoxydecane |
C11H24O |
7289-52-3 |
|
| Coumarin-3-carboxylicacid |
C10H6O4 |
531-81-7 |
|
| 2-Phenylbenzimidazole-5-sulfonic acid |
C13H10N2O3S |
27503-81-7 |
|
| 2,5-Diethylpyrazine |
C8H12N2 |
13238-84-1 |
|
| (S)-Benzyl (2-oxotetrahydrofuran-3-yl)carbamate |
C12H13NO4 |
35677-89-5 |
|
| 5-Methoxy-2-Nitrobenzoic Acid |
C8H7NO5 |
1882-69-5 |
|
| 3-(4-chlorophenoxy)propionic acid97% |
C9H9ClO3 |
3284-79-5 |
|
| (R)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)-6-methylphenyl)methanesulfonamide |
C14H20N2O3S |
871360-40-6 |
|
| ((4-{2-[(RS)-2-Amino-4,6-dioxo-4,5,6,7-tetrahydro-3H-pyrrolo[2,3- d]pyrimidin-5-yl]ethyl}benzoyl)-L-glutamic acid) |
C12H5N3O3 |
NA |
|
| 2,2'-(((6-Chloropyrimidine-2,4-diyl)bis(oxy))bis(methylene))dibenzonitrile |
C12H5N3O3 |
NA |
|
| 3-(2-(cyclopent-1-en-1-yl)-2-hydroxy-2-phenylacetoxy)- 1,1-dimethylpyrrolidin-1-ium bromide (Dehydro Glycopyrrolate Bromide) |
C12H5N3O3 |
NA |
|
| Allyl 2-(1-(isobutyramidomethyl)cyclohexyl)acetate; (GPT Allyl Impurity) |
C12H5N3O3 |
NA |
|
| 4-(nitrooxy)butyl 5-(triphenyl-l4- phosphaneyl)pentanoate; (Wittig Impurity) |
C12H5N3O3 |
NA |
|
| 1-(Isobutyryloxy)ethyl 3-oxo-2-azaspiro[4.5]decane-2- carboxylate; (GPT Cyclic Impurity) |
C12H5N3O3 |
NA |
|
| (S)3-(2-Amino-2-oxo-1,1-diphenylethyl)-1,1-bis(2-(2,3- dihydrobenzofuran-5-yl)ethyl)pyrrolidin-1-ium bromide; (Darifenacin Pyrrolidinium Dimer Impurity) |
C12H5N3O3 |
NA |
|
| N-(3-(5-Cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl)propyl)-N-methylnitrous amide; (N-Nitroso Desmethylcitalopram) |
C12H5N3O3 |
NA |
|
| Allyl 2-(1-(formamidomethyl)cyclohexyl)acetate; (Gabapentin formyl impurity) |
C12H5N3O3 |
NA |
|
| N-(2-((S)-2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-N-(3- hydroxyadamantan-1-yl)nitrous amide; (N-Nitroso Vildagliptin) |
C12H5N3O3 |
NA |
|
| 3,4 -Difluoro Dolutegravir |
C12H5N3O3 |
NA |
|
| 1-(2-Aminoethyl)-3-(5-bromoquinoxalin-6-yl)-1-((5- bromoquinoxalin-6-yl)carbamoyl)urea |
C12H5N3O3 |
NA |
|
| Bumetanide intermediate |
C12H5N3O3 |
NA |
|
| 5,5'-[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bis(cis- 1,2,3,4-tetrahydronaphthalene-2,3-diol); (Nadolol - Impurity C) |
C12H5N3O3 |
NA |
|
| (2-Chloro-3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamic acid cyclopentyl ester; (2-Chloro Zafirlukast) |
C12H5N3O3 |
NA |
|
| 2,4,6 -Trifluoro Dolutegravir |
C12H5N3O3 |
NA |
|
| 2-((4,6-Dimethoxypyrimidin-2-yloxy)methyl)benzonitrile |
C12H5N3O3 |
NA |
|
| cis-5-[(2RS)-2,3-Dihydroxypropoxy]-1,2,3,4- tetrahydronaphtalene-2,3-diol (Nadolol EP Impurity A) |
C12H5N3O3 |
NA |
|
| 2-Isobutyryl-2-azaspiro[4.5]decan-3-one; (Gabapentin impurity) |
C12H5N3O3 |
NA |
|
| Propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-2-[(3R)-3-(formyloxy)- 5-phenylpentyl]-3,5- dihydroxycyclopentyl]hept-5- enoate; (Latanoprost - Impurity A) |
C12H5N3O3 |
NA |
|
| 1-(4-((2,4-dimethylphenyl)thio)phenyl)-4-nitrosopiperazine; (N-Nitroso Vortioxetine Impurity) |
C12H5N3O3 |
NA |
|
| (3S)-3-Amino-1-[3-(trifluoromethyl)- 5,6-dihydro[1,2,4] triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl) butan-1-one hydrochloride |
C12H5N3O3 |
NA |
|
| 2-(11-(3-(Dimethylamino) propylidene)-6,11- dihydrodibenzo[b,e]oxepin-2-yl)-N-methoxy-N-methylacetamide |
C12H5N3O3 |
NA |
|
| 5-nitroso-5,11-dihydro-10H-dibenzo[b,f]azepin-10-one; (N Nitroso Oxcarbazepine EP Impurity C) |
C12H5N3O3 |
NA |
|
| 1-(2-((2,4-dimethylphenyl)thio)phenyl)-4-nitrosopiperazine; (N-Nitroso Vortioxetine) |
C12H5N3O3 |
NA |
|
| N-((1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4- tetrahydronaphthalen-1-yl)-N-methylnitrous amide; (Sertraline Nitroso Impurity) |
C12H5N3O3 |
NA |
|
| Isopropyl-(Z)-6-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3- hydroxy-5-phenylpentyl]cyclopentyl]-4-hexenoate; (2-Nor Latanoprost) |
C12H5N3O3 |
NA |
|
| 2,2'-(Ethane-1,1-diyl)bis(2-azaspiro[4.5]decan-3-one); (Gabapentin Dilactam Impurity) |
C12H5N3O3 |
NA |
|
| N-Benzyl-N-(1-(4-methoxyphenyl)propan-2-yl)nitrous amide; (N-Nitroso Formoterol Impurity 30) |
C12H5N3O3 |
NA |
|
| (Z)-2-(11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)-N,N-dimethylacetamide Hydrochloride |
C12H5N3O3 |
NA |
|
| Propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3-(formyloxy)-5- hydroxy-2-[(3R)-3-hydroxy-5- phenylpentyl]cyclopentyl]hept-5-enoate; (Latanoprost - Impurity B) |
C12H5N3O3 |
NA |
|
| (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((2R)-3-((S)-1-hydroxy-3-phenylpropyl)oxiran-2- yl)cyclopentyl)- N- ethylhept-5- enamide; (Bimatoprost 13,14-Epoxide) |
C12H5N3O3 |
NA |
|
| Propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-5-(formyloxy)-3- hydroxy-2-[(3R)-3-hydroxy-5- phenylpentyl]cyclopentyl]hept-5-enoate; (Latanoprost - Impurity C) |
C12H5N3O3 |
NA |
|
| 2-((4,6-Dichloropyrimidin-2-yloxy)methyl)benzonitrile |
C12H5N3O3 |
NA |
|
| 1-(2-((2,4-dimethylphenyl)sulfinyl)phenyl)-4-nitrosopiperazine |
C12H5N3O3 |
NA |
|
| (Z)-2-(11-(3-(methyl(nitroso)amino)propylidene)-6, 11-dihydrodibenzo[b, e]oxepin-2-yl)acetic acid; (N-Nitroso Olopatadine N-Desmethyl Impurity) |
C12H5N3O3 |
NA |
|
| Cyclopentyl (3-(4-carbamoyl-2-methoxybenzyl)-1- methyl-1H-indol-5-yl)carbamate |
C12H5N3O3 |
NA |
|
| Methyl N 5-chloro-1H-benzo[d]imidazol-2-ylcarbamate |
C9H8ClN3O2 |
20367-38-8 |
|
| BENZYL AZIDE |
C7H7N3 |
622-79-7 |
|
| D-ribose sugar |
C13H18O9 |
13035-61-5 |
|
| 7-Diethylaminocoumarin-3-carboxylic acid ethylester |
C16H19NO4 |
28705-46-6 |
|
| 2-Acetyl-5-norbornene |
C9H12O |
5063-03-6 |
|
| 5-Methoxyresorcinol |
C7H8O3 |
2174-64-3 |
|
| TRANS,TRANS-FARNESOL |
C15H26O |
106-28-5 |
|
| Sumaresinolic acid |
C30H48O4 |
559-64-8 |
|
| 2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate |
C9H20ClNO2 |
946511-97-3 |
|
| 3-methoxy-4-((1-methyl-5-nitro-1H-indol-3-yl) methyl)- N-(o-tolylsulfonyl) benzamide |
C25H23N3O6S |
143052-95-3 |
|
| (11Z)-11-[3-(Dimethylamino)propylidene]-6,11- dihydrodibenz[b,e]oxepin-2-acetamide |
C21H24N2O2 |
872040-99-8 |
|
| Diclofenac impurity-A |
C14H9Cl2NO |
15362-40-0 |
|
| 1-[2-[(5-Chloro-2,1,3-benzothiadiazol-4-yl)amino]-4,5- dihydro-1H-imidazol-1-yl]-ethanone (or) 1-Acetyl-N-(5- chloro-2,1,3-benzothiadiazol-4-yl)-4,5-dihydro-1H-imidazol-2-amine |
C11H10ClN5OS |
173532-15-5 |
|
| 3,5-Diiodo-L-tyrosine |
C9H13I2NO5 |
18835-59-1 |
|
| 4-Methoxyphenethyl bromide |
C9H11BrO |
14425-64-0 |
|
| 1,2-DIMETHYLPYRIDINIUM IODIDE |
C7H10IN |
872-73-1 |
|
| N-(Pyridin-2-ylmethyl)-2, 5-bis (2, 2, 2-trifluoroethoxy) benzamide |
C17H14F6N2O3 |
57415-36-8 |
|
| 4,4'-Bis(2-bromoacetyl)biphenyl |
C16H12Br2O2 |
4072-67-7 |
|
| Diphenyl ether |
C12H10O |
101-84-8 |
|
| N,N-Dimethyl-3-oxo-4-aza-5α-androst-1-ene-173- carboxamide |
C21H32N2O2 |
2512195-98-9 |
|
| Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-(phenylthio)-, (3R)- |
C15H21NO4S |
2349738-22-1 |
|
| 2-Bromo-1-[3-(1-methylethyl)phenyl]-ethanone |
C11H13BrO |
1429312-26-4 |
|
| 6-Chloro-4-methoxy-2-methyl-N-(pyridin-2-yl)-2H- thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide |
C14H12ClN3O4S2 |
2469039-23-2 |
|
| Harmine hydrochloride |
C13H13ClN2O |
343-27-1 |
|
| 5-bromo-2,4-dihydroxybenzoic acid |
C7H5BrO4 |
7355-22-8 |
|
| 2,6-dihydroxybenzaldehyde |
C7H6O3 |
387-46-2 |
|
| 4-Methylhippuric Acid |
C10H11NO3 |
27115-50-0 |
|
| 7-Methoxyflavone |
C16H12O3 |
22395-22-8 |
|
| CDMT |
C5H6ClN3O2 |
3140-73-6 |
|
| 3-(3-Fluorophenyl)propionic acid |
C9H9FO2 |
458-45-7 |
|
| 3-(dimethylamino)-1-phenylpropan-1-one |
C11H15NO |
3506-36-3 |
|
| N-(4-cyano phenyl)glycine |
C9H8N2O2 |
42288-26-6 |
|
| 7-Fluoro-1-indanone |
C9H7FO |
651735-59-0 |
|
| 1-Cyclohexylprop-2-en-1-one |
C9H14O |
2177-34-6 |
|
| (S)-2-{1-[3-(2-Bromoethyl)-4-hydroxyphenethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide |
C28H31BrN2O2 |
2468796- 89-4 |
|
| 2,3,5-Tri-O-benzyl-D-ribonolactone |
C26H26O5 |
55094-52-5 |
|
| Coumarine 314 |
C18H19NO4 |
55804-66-5 |
|
| 1-(pyrimidin-2-yl) propan-1-one |
C7H8N2O |
54643-09-3 |
|
| 2-Chloro-1-methylpyridinium iodide |
C6H7ClIN |
14338-32-0 |
|
| Clopidogrel Metabolite H1 |
C16H18ClNO4S |
1415550-28-5 |
|
| Beta-Bromostyrene |
C8H7Br |
103-64-0 |
|
| 5-Imino-4-methyl-4, 5-dihydro-1, 3, 4-thiadiazole-2- sulfonamide |
C3H6N4O2S2 |
86029-46-1 |
|
| (R)-bis((R)-1-phenylethyl)amine |
C16H20ClN |
82398-30-9 |
|
| 5-acetyl-8-hydroxyquinolin-2(1H)-one |
C11H9NO3 |
62978-73-8 |
|
| Phenol, 4,4‘-azobis-; 4,4'-azobis(phenol); Phenol,4,4'-azobis |
C12H10N2O2 |
2050-16-0 |
|
| Piperlongminine |
|
11836-52-7 |
|
| METHANE SULPHONYLAZIDE |
CH3N3O2S |
1516-70-7 |
|
| 4-(4-Amino-3-fluorophenoxy)-N-methylpyridine-2- carboxamide |
C13H12FN3O2 |
757251-39-1 |
|
| Telmisartan Methyl Ester |
C34H32N4O2 |
528560-93-2 |
|
| 5-Chloroindole-2-carboxylic acid |
C9H6ClNO2 |
10517-21-2 |
|
| Ticagrelor |
C23H28F2N6O4S |
274693-27-5 |
|
| (Ethyl 1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylate) |
C26H24N6O3 |
139481-58-6 |
|
